Multidisciplinary management controversies in laryngeal cancer

Annals of the Academy of Medicine Singapore

Volumn 25, Issue 3, 1996, Pages 405-412

  Goh, C ^a   O'Sullivan, B ^b   Warde, P ^b   Groome, P ^d   Gullane, P ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

Author keywords

cost; decision making; drug therapy; radiotherapy; surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

HUMAN; LARYNX CANCER; REVIEW;

CARCINOMA; DECISION MAKING; EDUCATION, MEDICAL; EVIDENCE-BASED MEDICINE; GOALS; HUMANS; LARYNGEAL NEOPLASMS; LARYNX; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT CARE PLANNING; PATIENT CARE TEAM; PATIENT PARTICIPATION; PATIENT SELECTION; PROFESSIONAL PRACTICE LOCATION; RANDOMIZED CONTROLLED TRIALS; SELECTION BIAS; SPECIALTIES, MEDICAL;

EID: 0029837649     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Howe H L, Bernstein L, Derrick L, Fulton J, Gentlemen J, Hankey B, et al. In: Howe H L, editor. Cancer Incidence in North America, 1988-1991. Berkeley, California: North American Association of Cancer Registries, 1995
2. Sasaki C T, Carlson R D. Malignant neoplasms of the larynx In: Cummings C W, Fredrickson J M, Krause C J, Harker L A, Schuller D E, editors. Otolaryngology - Head and Neck Surgery. Vol III. 2nd ed. St Louis: Mosby Year Book, 1992:1925-54
3. Natvig K. Study No. 1: Social, personal, and behavioral factors related to present mastery of the laryngectomy event. J Otolaryngol 1983, 12.155-62.
4. Shapiro P A, Kornfeld D S Psychiatric aspects of head and neck cancer surgery. Psychiatr Clin North Am 1987; 10:87-100.
5. Breitbart W, Holland J. Psychosocial aspects of head and neck cancer Semin Oncol 1988; 15.61-9.
6. Mathieson C M, Stam H J, Scott J P Psychosocial adjustment after laryngectomy a review of the literature J Otolaryngol 1990, 19:331-6.
7. Brown H G, Tai-Seale M. Vocational rehabilitation of cancer patients. Semin Oncol Nurs 1992, 8:202-11.
8. International Union against Cancer. Larynx. In Hermanek P, Sobin L H, editors. TNM Classification of Malignant Tumours 4th, 2nd revision ed. Berlin Heidelberg: Springer-Verlag, 1992:25-8
9. Bryce D, Biller H, Pearson B. Squamous cell carcinoma of the larynx Head Neck Surg 1986, 9:122-6.
10. Million R R The larynx ... so to speak: everything I wanted to know about laryngeal cancer I learned in the last 32 years. Int J Radiat Oncol Biol Phys 1992; 23:691-704.
11. Sessions R B, Harrison L B, Hong W K Tumors of the larynx and hypopharynx. In: DeVita V T, Hellman S, Rosenberg S A, editors. Principles and Practice of Oncology. 4th ed. Philadelphia. J B Lippincott, 1993:631-55.
12. Vokes E E, Weichselbaum R R, Lippman S M, Hong W K. Medical progress: head and neck cancer. N Engl J Med 1993, 328:184-94
13. Stalpers L J A, Verbeck A L M, van Daal W A J. Results of radiotherapy and surgery for glottic carcinoma. Cancer Treat Rev 1987, 14.131-41.
14. DeSanto L W, Olsen K D. Early glottic cancer. Am J Otol 1994; 15:242-9.
15. Mendenhall W M, Parsons J T, Stringer S P, Cassisi N J Management of Tis, T1, and T2 squamous cell carcinoma of the glottic larynx. Am J Otol 1994; 15.250-7.
16. Million R R, Cassisi N J. Larynx. In. Million R R, Cassisi N J, editors. Management of Head and Neck Cancer: A Multidisciplinary Approach 2nd ed. Philadelphia. J B Lippincott, 1994:431-97.
17. Hirano M, Kurita S, Matsuoka H. Vocal function following hemilaryngectomy Ann Otol Rhinol Laryngol 1987; 96:586-9
18. DelGaudio J M, Fleming D J, Esclamado R M, Carroll W R, Bradford C R. Hemilaryngectomy for glottic carcinoma after radiation failure. Arch Otolaryngol Head Neck Surg 1994; 120:959-63.
19. McGuirt W F, Blalock D, Koufman J A, Feehs R S, Hilliard A J, Greven K, et al Comparative voice results after laser resection or irradiation of T1 vocal cord carcinoma. Arch Otolaryngol Head Neck Surg 1994, 120.951-5
20. Robertson A G, Robertson C, Boyle P, Symonds R P, Wheldon T E The effects of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. Eur J Cancer 1993; 29A:501-10.
21. Wong J R, Wang C C. Preservation of organ and function in the treatment of laryngeal cancer. Cancer Invest 1995; 13:57-65.
22. Hao S P, Myers E N, Johnson J T. T3 glottic carcinoma revisited: transglottic vs pure glottic carcinoma. Arch Otolaryngol Head Neck Surg 1995; 121:166-70.
23. Haughey B H. Total laryngectomy and laryngopharyngectomy In: Cummings C W, Fredrickson J M, Krause C J, Harker L A, Schuller D E, editors. Otolaryngology - Head and Neck Surgery. Vol III. 2nd ed. St Louis: Mosby Year Book, 1992:2166-77
24. Gleeson M Voice after laryngectomy [editorial]. BMJ 1992; 304:2-3.
25. Johnson A Voice restoration after laryngectomy. Lancet 1994; 343:431-2.
26. Brandenburg J H, Patil N, Swift E W Modified neoglottis reconstruction following total laryngectomy: long term follow-up and results. Laryngoscope 1995; 105:714-6.
27. Pearson B W. Subtotal laryngectomy. Laryngoscope 1981; 91:1904-12.
28. Piquet J J, Chevalier D. Subtotal laryngectomy with crico-hyoido-epiglottopexy for the treatment of extended glottic carcinomas. Am J Surg 1991; 162:357-61.
29. Schecter G L. Conservation surgery of the larynx. In: Cummings C W, Fredrickson J M, Krause C J, Harker L A, Schuller D E, editors. Otolaryngology - Head and Neck Surgery. Vol III. 2nd ed. St Louis: Mosby Year Book, 1992:1925-54.
30. Laccourreye O, Crevier-Buchman L, Weinstein G, Biacabe B, Laccourreye H, Brasnu D. Duration and frequency characteristics of speech and voice following supracricoid partial laryngectomy. Ann Otol Rhinol Laryngol 1995, 104:516-21.
31. Peters L J, Ang K K. The role of altered fractionation in head and neck cancer. Semin Radiat Oncol 1992; 2 180-94.
32. Harari P M, Kinsella T J. Advances in radiation therapy for head and neck cancer. Curr Opin Oncol 1995; 7 248-54.
33. Pfister D G, Strong E, Harrison L, Haines I E, Pfister D A, Sessions R, et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 1991; 9 850-9.
34. Forastiere A. Neoadjuvant chemotherapy and organ preservation: overview and future directions. In. Johnson J T, Didolkar M S, editors. Head and Neck Cancer. Vol III. Amsterdam: Excerpta Medica, 1993:13-6.
35. The Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991; 324:1685-90.
36. Tannock I F, Cummings B J Neoadjuvant chemotherapy in head and neck cancer no way to preserve a larynx [letter] J Clin Oncol 1992; 10:343-4.
37. Jaulerry C, Rodriguez J, Brunin F, Jouve M, Mosseri V, Point D, et al. Induction chemotherapy in advanced head and neck tumours: results of two randomised trials. Int J Radiat Oncol Biol Phys 1992; 23:483-9.
38. O'Sullivan B, Mackillop W, Gilbert R, Gaze M, Lundgren J, Atkinson C, et al. Controversies in the management of laryngeal cancer: results of an international survey of patterns of care Radiother Oncol 1994; 31:23-32.
39. Priestman T J, Bullimore J A, Godden T P, Deutsch G P. The Royal College of Radiologists' fractionation survey. Clin Oncol 1989, 1:39-46.
40. O'Sullivan B, Mackillop W J. An approach to the interpretation of the literature of head and neck cancer. In: Keane T, Briant T, editors. Clinics in Oncology. Vol V. London W B Saunders, 1986 411-33
41. Cox J D. Evolution and accomplishments of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1995; 33:747-54
42. Eddy D M. A manual for assessing health practices and designing practice policies: the explicit approach. Philadelphia, PA: American College of Physicians, 1992.
43. Till J E, Sutherland H J, Meslin E M. Is there a role for preference assessments in research on quality of life in oncology? Qual Life Res 1992; 1.31-40.
44. Stalpers L J A, Verbeek A L M, van Daal W A J Radiotherapy or surgery for T2N0M0 glottic carcinoma? A decision-analytic approach. Radiother Oncol 1989; 14.209-17
45. Maas A, Stalpers L. Assessing utilities by means of conjoint measurement. Med Decis Making 1992; 12:288-97.
46. Sagar S M, McKenna G, Nolan M C. A clinical audit of glottic cancer in Nova Scotia: a paradigm for effectiveness research. Clin Oncol 1994; 6:14-23.
47. van der Donk J, Levendag P C, Kuijpers A J, Roest F H J, Habbema J D F, Meeuwis C A, et al. Patient participation in clinical decision-making for treatment of T3 laryngeal cancer: a comparison of state and process utilities. J Clin Oncol 1995; 13:2369-78.
48. McNeil B J, Weichselbaum R, Pauker S G. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med 1981; 305:982-7.
49. Parker R G. Varying charges for comparably effective cancer treatments. Am J Clin Oncol 1992; 15:281-7.
50. Mittal B, Rao D V, Marks J E, Ogura J H. Comparative cost analysis of hemilaryngectomy and irradiation for early glottic carcinoma. Int J Radiat Oncol Biol Phys 1983; 9:407-8.
51. Griffen T W, Mythen L. The effect of the health care systems on choice of treatment for carcinomas of the larynx, or a tale of two cities. In: Johnson J T, Didolkar M S, editors. Head and Neck Cancer. Vol III. Amsterdam Excerpta Medica, 1993:237-41.
52. Myers E N, Wagner R L, Johnson J T. Microlaryngoscopic surgery for T1 glottic lesions: a cost-effective option. Ann Otol Rhinol Laryngol 1994; 103:28-30.
53. Wolf G T, Hong W K. Induction chemotherapy for organ preservation in advanced laryngeal cancer: is there a role? Head Neck 1995; 17:279-83.
54. Laramore G E. T3N0M0 glottic cancer: are more treatment modalities necessarily better? Int J Radiat Oncol Biol Phys 1995; 31:423-5.